{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:42:00Z","timestamp":1789994520771,"version":"4.0.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2018.00363","type":"journal-article","created":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T08:01:42Z","timestamp":1539849702000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and\/or Colistin-Resistant Enterobacteriaceae"],"prefix":"10.3389","volume":"8","author":[{"given":"Tania","family":"Cebrero-Cangueiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"\u00c1lvarez-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Labrador-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"Smani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cordero-Mat\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Pach\u00f3n-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-0691.2012.03823.x","article-title":"Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria","volume":"18","author":"Akova","year":"2012","journal-title":"Clin. Microbiol. Infect"},{"key":"B2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Cant\u00f3n","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B3","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard\u2014Ninth Edition","year":"2012"},{"key":"B4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijantimicag.2011.10.012","article-title":"Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli","volume":"39","author":"Docobo-P\u00e9rez","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B6","year":"2018","journal-title":"European Society of Clinical Microbiology and Infectious Diseases. Clinical Breakpoints"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1128\/AAC.00466-15","article-title":"Heteroresistance to itraconazole alters the morphology and increases the virulence of Cryptococcus gattii","volume":"59","author":"Ferreira","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12275-018-7449-0","article-title":"Colistin resistance in Enterobacter spp. isolates in Korea","volume":"56","author":"Hong","year":"2018","journal-title":"J. Microbiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ijantimicag.2016.09.016","article-title":"Colistin use and colistin resistance in bacteria from animals","volume":"48","author":"Kempf","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ijantimicag.2014.08.006","article-title":"Characterisation of the first ongoing outbreak due to KPC-3-producing Klebsiella pneumoniae (ST512) in Spain","volume":"44","author":"L\u00f3pez-Cerero","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10096-012-1737-0","article-title":"Prevalence and molecular epidemiology of acquired AmpC beta-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain","volume":"32","author":"Mir\u00f3","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/cbdv.200590111","article-title":"Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin","volume":"2","author":"Nguewa","year":"2005","journal-title":"Chem. Biodivers."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2015.11.009","article-title":"Emergence of colistin-resistant bacteria in humans without colistin usage: a new worry and cause for vigilance","volume":"47","author":"Olaitan","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1128\/AAC.00086-15","article-title":"Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem","volume":"59","author":"Oteo","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1128\/AAC.00367-09","article-title":"Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii","volume":"54","author":"Pach\u00f3n-Ib\u00e1\u00f1ez","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3389\/fmicb.2018.00912","article-title":"Efficacy of colistin and its combination with rifampin in vitro and in experimental models of infection caused by carbapenemase-producing clinical isolates of Klebsiella pneumoniae","volume":"9","author":"Pach\u00f3n-Ib\u00e1\u00f1ez","year":"2018","journal-title":"Front. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijantimicag.2010.10.031","article-title":"Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay","volume":"37","author":"Pournaras","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00079","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of infections caused by extended-spectrum-beta-lactamase-, ampc-, and carbapenemase-producing enterobacteriaceae","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.eimc.2017.08.012","article-title":"Direct bacterial identification from positive blood cultures using matrix-assisted laser desorption\/ionization time-of-flight (MALDI-TOF) mass spectrometry: A systematic review and meta-analysis","volume":"36","author":"Ruiz-Arag\u00f3n","year":"2018","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1128\/AAC.01086-10","article-title":"In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development","volume":"55","author":"Souli","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","unstructured":"SoussyC. J.\n          Antibiogram Committee of the French Society for Microbiology, Recommendations2012"},{"key":"B23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nrd3957-c1","article-title":"The value of single-pathogen antibacterial agents","volume":"12","author":"Spellberg","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B24","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat. Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/21505594.2017.1292196","article-title":"Therapeutic options for carbapenem-resistant Enterobacteriaceae infections","volume":"8","author":"Trecarichi","year":"2017","journal-title":"Virulence"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5720417","DOI":"10.1155\/2018\/5720417","article-title":"Synergistic activity of colistin\/fosfomycin combination against carbapenemase-Producing Klebsiella pneumoniae in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed Res. Int."},{"key":"B27","volume-title":"Priority List of Antibiotic-resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics","year":"2017"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.2174\/1381612821666150506154434","article-title":"Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections","volume":"21","author":"Younis","year":"2015","journal-title":"Curr. Pharm. Des."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T08:01:54Z","timestamp":1539849714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":28,"alternative-id":["10.3389\/fcimb.2018.00363"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2018.00363","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]},"article-number":"363"}}